The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages.
Open accessAbstract
The scavenger receptor (ScR) mediates uptake of chemically modified low density lipoprotein (LDL) by human monocyte-derived macrophages. It is not down-regulated by high intracellular cholesterol levels, and exposure of macrophages to acetylated or oxidized LDL therefore leads to foam cell development. The hypothesis that this represents an important mechanism for intracellular cholesterol accumulation in atherosclerosis is supported by the finding of ScR expression in foam cells of atherosclerotic plaques. T lymphocytes are also present in such plaques and it is known that T cell products regulate macrophage activation. We have therefore studied the effect of interferon-gamma (IFN gamma), a lymphokine secreted by activated T lymphocytes, on the expression of ScR in human monocyte-derived macrophages. Binding and uptake of acetylated LDL were significantly reduced in macrophages exposed to recombinant IFN gamma or IFN gamma-containing lymphocyte-conditioned media. Competition experiments showed that the IFN gamma-regulated binding and uptake of acetylated LDL was mediated via ScR. IFN gamma exerted its effect on the saturable binding of acetylated LDL by reducing the number of cell surface binding sites without significantly affecting the affinity between acetylated LDL and its receptor. Northern analysis revealed that the type I ScR mRNA was significantly reduced in IFN gamma-treated cells. Finally, IFN gamma treatment reduced intracellular cholesteryl ester accumulation and inhibited the development of foam cells in the cultures. In conclusion, our data show that IFN gamma blocks the development of macrophage-derived foam cells by inhibiting expression of ScR. This suggests that macrophage-T lymphocyte interactions may reduce intracellular cholesterol accumulation in the atherosclerotic plaque.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Purification of Mouse Immunoglobulin Heavy‐Chain Messenger RNAs from Total Myeloma Tumor RNA
AUFFRAY, C., & ROUGEON, F. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06030.x · Cited by 2,627
Lipid extraction of tissues with a low-toxicity solvent
Hara, A., & Radin, N. S. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90046-5 · Cited by 2,559
Goldstein, J. L., Ho, Y. K., Basu, S. K., & Brown, M. S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.333 · Cited by 2,448
LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
Brown, M. S., & Goldstein, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001255 · Cited by 2,300
The Cell Biology of Macrophage Activation
Adams, D. (1984) · Annual Review of Immunology · doi:10.1146/annurev.immunol.2.1.283 · Cited by 1,604
Jonasson, L., Holm, J., Skalli, O., Bondjers, G., & Hansson, G. K. (1986) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.6.2.131 · Cited by 1,335
Self-citationRg, G. (1981) · PubMed Central · Cited by 1,314
Voyta, J. C., Via, D. P., Butterfield, C. E., & Zetter, B. R. (1984) · The Journal of cell biology · doi:10.1083/jcb.99.6.2034 · Cited by 1,239
Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils
Kodama, T., Freeman, M., Rohrer, L., Zabrecky, J., Matsudaira, P., & Krieger, M. (1990) · Nature · doi:10.1038/343531a0 · Cited by 1,041
Detection of activated T lymphocytes in the human atherosclerotic plaque.
Hansson, G. K., Holm, J., & Jonasson, L. (1989) · Europe PMC (PubMed Central) · Cited by 744
Self-citationGown, A. M., Tsukada, T., & Ross, R. (1986) · PubMed · Cited by 676
Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages.
Schaffner, T., Taylor, K., Bartucci, E. J., Fischer-Dzoga, K., Beeson, J. H., Glagov, S., & Wissler, R. W. (1980) · PubMed · Cited by 476
Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II
Rohrer, L., Freeman, M., Kodama, T., Penman, M., & Krieger, M. (1990) · Nature · doi:10.1038/343570a0 · Cited by 457
Dimitriu-Bona, A., Burmester, G. R., Waters, S. J., & Winchester, R. J. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.1.145 · Cited by 393
Ylä-Herttuala, S., Rosenfeld, M. E., Parthasarathy, S., Sigal, E., Särkioja, T., Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115111 · Cited by 379
Matsumoto, A., Naito, M., Itakura, H., Ikemoto, S., Asaoka, H., Hayakawa, I., Kanamori, H., Aburatani, H., Takaku, F., & Suzuki, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9133 · Cited by 358
Jonasson, L., Holm, J., Skalli, O., Gabbiani, G., & Hansson, G. K. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111934 · Cited by 311
Self-citationFreeman, M., Ashkenas, J., Rees, D. J., Kingsley, D. M., Copeland, N. G., Jenkins, N. A., & Krieger, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8810 · Cited by 309
Hansson, G. K., Hellstrand, M., Rymo, L., Rubbia, L., & Gabbiani, G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.5.1595 · Cited by 268
Self-citationHansson, G. K., Jonasson, L., Holm, J., Clowes, M. M., & Clowes, A. W. (1988) · Circulation Research · doi:10.1161/01.res.63.4.712 · Cited by 250
Self-citationFogelman, A. M., Haberland, M. E., Seager, J., Hokom, M., & Edwards, P. A. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40672-8 · Cited by 230
Studies on the assembly of apo B-100-containing lipoproteins in HepG2 cells.
Boström, K., Borén, J., Wettesten, M., Sjöberg, A., Bondjers, G., Wiklund, O., Carlsson, P., & Olofsson, S. O. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68945-8 · Cited by 189
Mokoena, T., & Gordon, S. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111740 · Cited by 117
Warner, S. J., Friedman, G. B., & Libby, P. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113998 · Cited by 114
Molecular interactions in macrophage activation
Adams, D. O. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90298-3 · Cited by 101
Induction of acetyl-LDL receptor activity by phorbol ester in human monocyte cell line THP-1.
Via, D. P., Pons, L., Dennison, D., Fanslow, A. E., & Bernini, F. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38230-4 · Cited by 92
Hara, H., Tanishita, H., Yokoyama, S., Tajima, S., & Yamamoto, A. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90601-2 · Cited by 85
Vogt, R. F., Cross, G. D., Henderson, L. O., & Phillips, D. L. (1989) · Cytometry · doi:10.1002/cyto.990100308 · Cited by 76
Macrophage lipoprotein receptors
Fogelman, A. M., Lenten, B. J. V., Warden, C. H., Haberland, M. E., & Edwards, P. A. (1988) · Journal of Cell Science · doi:10.1242/jcs.1988.supplement_9.7 · Cited by 76
Fogelman, A. M., Seager, J., Haberland, M. E., Hokom, M. M., Tanaka, R., & Edwards, P. A. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.3.922 · Cited by 52
Lopes-Virella, M. F., Klein, R. L., & Stevenson, H. C. (1987) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.7.2.176 · Cited by 51
Interferon-gamma inhibits lipoprotein lipase in human monocyte-derived macrophages
Jonasson, L., Hansson, G. K., Bondjers, G., Noé, L., & Etienne, J. (1990) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(90)90024-8 · Cited by 47
Self-citationSuppression of aortic atherosclerosis in cholesterol-fed rabbits by purified rabbit interferon.
Wilson, A. C., Schaub, R. G., Goldstein, R. C., & Kuo, P. T. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.2.208 · Cited by 46
Lipoprotein uptake in primary cell cultures of rabbit atherosclerotic lesions
Jaakkola, O., Kallioniemi, O., & Nikkari, T. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90022-6 · Cited by 32
Effects of activation on lipid and lipoprotein metabolism in murine macrophages.
Kraemer, F. B., Tavangar, K., Gandjei, R. K., Kirlew, K., & Behr, S. R. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.1.8 · Cited by 23
Cited by
Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,044
Frostegård, J., Ulfgren, A.-K., Nyberg, P., Hedin, U., Swedenborg, J., Andersson, U., & Hansson, G. K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00011-8 · Cited by 1,002
Self-citationT lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.
Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J. L., & Hansson, G. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3893 · Cited by 943
Self-citationImmune Mechanisms in Atherosclerosis
Hansson, G. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1201.100220 · Cited by 876
Self-citationIFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 868
Metadata
- Authors
- Geng, Y. J., & Hansson, G. K.
- Venue
- Journal of Clinical Investigation
- Published
- 1992-04-01
- Volume
- 89
- Issue
- 4
- Pages
- 1322-1330
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2160454112
- Cited by
- 265
- References
- 37
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.